Targeting loss of the Hippo signaling pathway in <i>NF2</i>-deficient papillary kidney cancers
Carole Sourbier(Center for Drug Evaluation and Research), W. Marston Linehan(Harvard University)
Cited by 57
Related Papers
Vitamins C and E and Beta Carotene Supplementation and Cancer Risk: A Randomized Controlled Trial
|JNCI Journal of the National Cancer Institute|2008|311
Recent Advances in Targeting ROS1 in Lung Cancer
|Journal of Thoracic Oncology|2017|259
Clinicopathologic and Genomic Factors Impacting Efficacy of First-Line Chemoimmunotherapy in Advanced NSCLC
|Journal of Thoracic Oncology|2023|91
Brigatinib in Patients With Alectinib-Refractory ALK-Positive NSCLC
|Journal of Thoracic Oncology|2018|82
Somatic Cell Fusions Reveal Extensive Heterogeneity in Basal-like Breast Cancer
|Cell Reports|2015|75